Friday, 20 Jul 2018

You are here

The RheumNow Week in Review - 23 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. New announcements and approval from the FDA; novel associations between ANCA vasculitis and thyroid disease; flare rates after arthroplasty; and pregnancy outcomes for men and women.

  1. FDA Arthritis Advisory Committee will meet on April 23rd to discuss the NDA for Eli Lilly's JAK inhibitor - baricitinib in moderate to severe RA. Discussion will be around risk:benefit assessment, dose selection & the risk of venous thromboembolic events. https://t.co/dQ4AdYZyQx
  2. FDA Approves Ilumya (tildrakizumab) for Moderate-to-Severe Plaque Psoriasis. It binds p19 subunit of IL-23, inhibiting binding to IL-23 receptor. Given as 100 mg sc at Wk 0, 4 & q 12wks; this is the2nd IL-23 inhib approved for Pso. https://t.co/q9bQTVqN0t
  3. Norfolk registry study of 431 inflammatory arthritis pts shows 82% still on MTX after 2 years. Early MTX failure associated with RF+, younger onset age, high DAS-28. MTX discontinuations for AE less likely if RF-positive https://t.co/kOrfaCnZaf
  4. In a RCT of 106 hip osteoarthritis patients, intramuscular glucocorticoid injection shown to be significantly better than placebo injx in all outcomes for up to 12-weeks https://t.co/csGXkQQwjh
  5. Study from German RABBIT Registry of 885 RA patients treated with tocilizumab finds that treatment success with TCZ similar in pts with no, 1 or 2 prior bDMARD failures, but less with with ≥ 3 bDMARD failures. https://t.co/jAriEaPruP
  6. Study of 279 patients with ANCA Associated vasculitis shows a high prevalence of thyroid disease - 21.5% - mostly females with MPO Abs and renal disease. https://t.co/7QGZrcSnLJ
  7. Flares are frequent in patients in 120 RA undergoing arthroplasty (THA, TKA); by 6 wks 63%. Flare more freq with higher disease activity (OR=2), ESR, CRP, Pain; but not affected by biologic use. https://t.co/4hdn5nTQZO
  8. Pregnancy study from Quebec finds 51 Pregs exposed to leflunomide during 1st trimester; 21 during the 2nd/3rd trimesters but was not associated with an increased risk of congenital malformations, Spont Ab, low birth weight or prematurity https://t.co/WiqyOkg3L2
  9. Danish/Swedish study of 8097 births in 6103 psoriasis women & 964 births in 753 PsA women shows increased number of maternal gestational DM, HTN & preeclampsia; and more cesarean delivery, pre-term birth & low birth weight infants; moreso with severe psoriasis https://t.co/DjrNqiRlgA
  10. Risk of Paternal Exposure to Anti-Rheumatic Drugs  
  11. Shoe Inserts Disappoint with Plantar Heel Pain  
  12. mTOR Inhibition with Sirolimus Effective in Lupus  

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – Cocoon Therapy? (7.20.18)

Dr. Jack Cush reviews highlights from the news and social media on RheumNow.com in the past week. 

Proposed Changes for 2019 Medicare Fee Schedule

On July 12th the Centers for Medicare & Medicaid Services (CMS) released its proposed rule changes for the 2019 Medicare physician fee schedule.  This year, CMS has combined the Medicare physician fee schedule proposed rule with recommendations for the Quality Payment Program (QPP), which will be officially published in the Federal Register on July 27.

Trend Towards Fewer Self-Employed Physicians

 

A nationwide survey study analyzed healthcare provider (HCP) employment type (self-employed, employed by private sector, or employed by government) and annual labor earnings (2001 to 2015) and found that the health care landscape is changing with few self-employed practitioners and more being larger organizations. 

The RheumNow Week in Review –Fateful Outcomes in Rheumatology (7.13.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  Fateful outcomes in Rheumatology, what happens to Seronegatives, IL-23 fails, MRI progression, Not all inflammatory back pain becomes SpA:

The RheumNow Week in Review – Life Savers for Rheumatologists (6.29.18)

Dr. Jack Cush reviews selected news and journal reports from the past week on RheumNow.com.